124,37 €
138,19 €
-10% with code: EXTRA
Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers
Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers
124,37
138,19 €
  • We will send in 10–14 business days.
The book broadly deals with therapeutic monoclonal antibodies (mAbs) and various relevant topics, including different antibody formats such as Antibody-Drug Conjugates (ADC), bispecifics, nanoparticle-based mAbs and HER2+ cancers, immune checkpoint inhibitors and other closely related topics. Each paper was written by leading active research groups in their fields both from academia and industry. The book should be of interest to those scientists and researchers who develop or use biologics, bi…
  • Publisher:
  • ISBN-10: 3036526870
  • ISBN-13: 9783036526874
  • Format: 17 x 24.4 x 2.4 cm, hardcover
  • Language: English
  • SAVE -10% with code: EXTRA

Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers (e-book) (used book) | bookbook.eu

Reviews

Description

The book broadly deals with therapeutic monoclonal antibodies (mAbs) and various relevant topics, including different antibody formats such as Antibody-Drug Conjugates (ADC), bispecifics, nanoparticle-based mAbs and HER2+ cancers, immune checkpoint inhibitors and other closely related topics. Each paper was written by leading active research groups in their fields both from academia and industry. The book should be of interest to those scientists and researchers who develop or use biologics, biotherapeutics, biosimilars and biobetters in cancer treatment.

EXTRA 10 % discount with code: EXTRA

124,37
138,19 €
We will send in 10–14 business days.

The promotion ends in 15d.14:16:49

The discount code is valid when purchasing from 10 €. Discounts do not stack.

Log in and for this item
you will receive 1,38 Book Euros!?
  • Publisher:
  • ISBN-10: 3036526870
  • ISBN-13: 9783036526874
  • Format: 17 x 24.4 x 2.4 cm, hardcover
  • Language: English English

The book broadly deals with therapeutic monoclonal antibodies (mAbs) and various relevant topics, including different antibody formats such as Antibody-Drug Conjugates (ADC), bispecifics, nanoparticle-based mAbs and HER2+ cancers, immune checkpoint inhibitors and other closely related topics. Each paper was written by leading active research groups in their fields both from academia and industry. The book should be of interest to those scientists and researchers who develop or use biologics, biotherapeutics, biosimilars and biobetters in cancer treatment.

Reviews

  • No reviews
0 customers have rated this item.
5
0%
4
0%
3
0%
2
0%
1
0%
(will not be displayed)